Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA...

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• The indirect excitotoxicity hypothesis suggests mitochondrial dysfunction increases neuronal calcium (Ca2+) entry via NMDA-receptor (NMDA-R) hypersensitivity.
• Investigating the role of mitochondrial defects in excitotoxicity is crucial for understanding neurodegenerative diseases.

Purpose of the Study:

• To test if mitochondrial complex II inhibition by 3-nitropropionic acid (3NP) exacerbates quinolinic acid (QA)-induced excitotoxicity in rat striatum.
• To determine if this potentiation involves NMDA-R hypersensitivity or intracellular Ca2+ deregulation.

Main Methods:

• Partial inhibition of mitochondrial complex II using 3-nitropropionic acid (3NP) in rat striatum and cultured striatal cells.
• Administration of the NMDA-R agonist quinolinic acid (QA) to assess excitotoxicity.
• Measurement of calpain activity and cleavage of postsynaptic proteins.
• In vivo brain imaging using [(18)F]fluorodeoxyglucose and 45Ca2+ uptake studies.

Main Results:

• Nontoxic 3NP treatment significantly enhanced QA-induced striatal degeneration.
• This potentiation was linked to increased calpain activity and postsynaptic protein cleavage, indicating Ca2+ deregulation.
• 3NP did not increase QA-induced ionic perturbations at glutamatergic synapses in vivo.
• Exacerbation of QA toxicity by 3NP was not due to increased Ca2+ entry into neurons.

Conclusions:

• Mitochondrial defects potentiate NMDA-R-mediated excitotoxicity primarily through intracellular Ca2+ deregulation.
• This occurs independently of NMDA-R hypersensitivity to glutamate.
• The findings challenge the indirect excitotoxicity hypothesis and highlight novel mechanisms in neuronal injury.